Gunilla holds an MD, PhD and Associate Professor from Karolinska Insitute. Her wide-ranging experience covers all phases of drug development in small, medium and large companies. She is a co-founder of Gesynta Pharma and holds several board positions.
Shares in the company: 88,420
Employee warrants: 190,897
Independence: Gunilla is independent in relation to the company and is independent in relation to the Company’s largest shareholders.